Evidence mapPaperPMID 42042914Full record

ReviewMetabolites2026

Precision Exercise in Type 2 Diabetes Mellitus: Targeting Signaling Networks for Lipid Homeostasis.

Tan Tian, Feiyang Yu, Xingran Liu, Xuelin Zeng, Jianjun Yue, Shanjun Bao

Abstract readReview
In one paragraph

Review in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Tan TianSchool of Sports Training, Wuhan Sports University, Wuhan 430079, China.
Feiyang YuSchool of Sports Training, Wuhan Sports University, Wuhan 430079, China.
Xingran LiuSchool of Physical Education and Health, Guangxi Medical University, Nanning 530021, China.
Xuelin ZengSchool of Sports Training, Wuhan Sports University, Wuhan 430079, China.
Jianjun YueCollege of Physical Education, Anhui Normal University, Wuhu 241002, China.
Shanjun BaoSchool of Sports Training, Wuhan Sports University, Wuhan 430079, China.

Funding

Anhui Normal University National Social Science FoundationGuangxi Medical University 2025GXNSFBA069048
6 · The paper itself

Abstract

Type 2 diabetes mellitus (T2DM) is frequently complicated by dyslipidemia, which accelerates insulin resistance and the progression of cardiovascular and hepatic diseases. While exercise intervention is a cornerstone of T2DM management, a systems-level understanding of its underlying molecular mechanisms remains incomplete. This article summarizes current evidence to propose that exercise functions as a signaling network regulator, concurrently modulating critical lipid metabolism-related signaling pathways: cyclic adenosine monophosphate (cAMP), phosphatidylinositol 3-kinase-protein kinase B (PI3K-AKT), forkhead box O (FOXO), and mitogen-activated protein kinase (MAPK) signaling pathways. We delineate how dysregulation of these signaling pathways contributes to lipid disorders in T2DM, highlighting their tissue-specific and often bidirectional roles. Subsequently, we detail the molecular adaptations induced by various exercise modalities-from aerobic training to high-intensity intervals-that restore homeostasis of this signaling network. By integrating these findings, we present a novel framework for precision exercise-defined as the tailoring of exercise modality, intensity, and volume based on an individual's predominant signaling pathway disturbance, assessed via circulating or tissue-specific biomarkers. This framework advocates for future exercise prescriptions to be guided by molecular profiling alongside traditional physiological indicators. This mechanistic insight not only deepens our comprehension of exercise physiology but also paves the way for more effective, personalized strategies to combat T2DM and its metabolic complications.

Indexed as

exercise interventionlipid metabolism disorderssignaling pathwaytype 2 diabetes mellitus (T2DM)

Identifiers

PMID42042914
PMCPMC13117746

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.